BURST CME™: Taking ALS Management to the Next Level
BURST CME™: Taking ALS Management to the Next Level is organized by Physicians' Education Resource, LLC (PER).
Release Date: March 27, 2023
Expiration Date: March 27, 2024
Description:
The neurodegeneration characteristic of amyotrophic lateral sclerosis (ALS) progressively affects a patient’s body regions, frequently limiting survival to 2 to 5 years after disease onset. The aims of management are to extend quality of life and slow disease progression. Patients with ALS have had limited disease-modifying treatment options, but the recent availability of new therapies and continuing development of investigational agents is leading to exciting advances in ALS care.
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of ALS with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of supportive care and current and investigational therapies will be presented in a multimedia format, including a series of audio interviews with an expert thought leader integrated into text-based elements.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Assess clinical trial data as well as the therapeutic rationale of new and emergent agents for the management of ALS
• Formulate personalized treatment plans for patients with ALS that take into account formulation options.